ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

Last updated:

Senda Biosciences - About the company

Senda Biosciences is a series C company based in Cambridge (United States), founded in 2019 by . It operates as a Manufacturer of drugs for multiple therapeutic areas. Senda Biosciences has raised $266M in funding from investors like Mayo Clinic, Alexandria and TMCP.

Company Details

Website
Social
Email ID
@sendabiosciences.com
Key Metrics
Founded Year
2019
Location
Cambridge, United States
Stage
Series C
Total Funding
in 2 rounds
Latest Funding Round
Investors

Senda Biosciences's funding and investors

Senda Biosciences has raised a total funding of $266M over 2 rounds. Its first funding round was on Jun 10, 2021. Its latest funding round was a Series C round on Aug 16, 2022 for $123M. 7 investors participated in its latest round, which includes Flagship Pioneering, Alexandria, Qatar Investment Authority and Stage 1 Ventures.

Senda Biosciences has 11 institutional investors including Mayo Clinic, Alexandria and TMCP.

Here is the list of recent funding rounds of Senda Biosciences:
Date of funding
Funding Amount
Round Name
Post money valuation
Revenue multiple
Investors
Aug 16, 2022
$123M
Series C
3209571
3164565
Jun 10, 2021
$98M
Series B
7627653
7370920
lockAccess funding benchmarks and valuations. Sign up today!

Senda Biosciences's founders and board of directors

The founders of Senda Biosciences is . , and are the CEO of Senda Biosciences. has founded 13 more companies including Abiologics, Prologue Medicines and Ampersand.

Senda Biosciences's Investments and acquisitions

Senda Biosciences has made no investments or acquisitions yet.

Reports related to Senda Biosciences

Here is the latest report on Senda Biosciences's sector:
View

News related to Senda Biosciences

•
STAT•Oct 19, 2023•Laronde, Senda Biosciences
•
Business Wire•Jan 12, 2023•Senda Biosciences, NTNU, Trinity College Dublin
•
Tullahoma News•Dec 14, 2022•Senda Biosciences
•
kedglobal.com•Aug 17, 2022•Senda Biosciences, , Samsung BioLogics
•
Pharmaceutical Business Review•Aug 17, 2022•Senda Biosciences, , Qatar Investment Authority, Stage 1 Ventures
•
BioPharmaDive•Aug 16, 2022•Senda Biosciences, Flagship Pioneering
•
PR Newswire•Jan 26, 2022•Senda Biosciences, Korro Bio
•
FinSMEs•Jun 12, 2021•Senda Biosciences, Magnum Partners
•
Global Legal Chronicle•Feb 22, 2021•Nestlé Health Science, Senda Biosciences
•
FFOODS Spectrum•Feb 04, 2021•Senda Biosciences, Nestlé Health Science
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
  • check icon 4M+ Companies
  • check icon 212K+ Investors
  • check icon 580K+ Funding Rounds
  • check icon 207K+ Acquisitions
  • check icon 2.9K+ Sectors
  • check icon 57K+ Business Models

Accel PartnersPartechIN-Q-TEL - USPalo Alto NetworkMaersk GrowthFujitsuTenityStanford
Are you a Founder ?

FAQ's about Senda Biosciences

Explore our recently published companies
  • Nav24 - Bielsko-biala based, Unfunded company
  • - Bengaluru based, 2024 founded, Unfunded company
  • Maximor - New York City based, 2023 founded, Unfunded company
  • withpi - San Francisco based, Unfunded company
  • ElseWare - Crawley based, 1995 founded, Acquired company
  • StrikeIT - Lucknow based, 2020 founded, Unfunded company
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long